Thyroid hormone exerts marked effects on cardiovascular function. Expr
ession of cardiac alpha- and beta-myosin heavy chain (MHC) isoforms ca
n be altered in response to thyroid hormone as well as by hemodynamic
changes imposed on the heart. The molecular mechanisms that mediate th
ese changes are not completely known. We studied the contractile and t
hyroid hormone responsiveness of the beta MHC promoter in both culture
d cardiac myocytes and in vivo by direct DNA transfer. Using transient
transfection of neonatal rat cardiomyocytes, the activities of recomb
inant reporter plasmids containing beta MHC 5'-flanking sequences term
inating at positions -2250, -1145, -670, and -354 were decreased signi
ficantly in cultures containing L-T-3 (50 nM). Similar deletion analys
is showed that 5'-flanking regions terminating within -2250 to -151 bp
were contractily responsive; however, deletion to position -126 atten
uated this response. In vivo beta MHC promoter activity, determined by
injecting the recombinant plasmid into the myocardium, was significan
tly higher by 2-fold in hypothyroid than in euthyroid ventricles (2.47
+/- 0.41 vs. 1.33 +/- 0.25 luciferase(chloramphenicol acetyltransfera
se; P < 0.05). Increased ventricular workload, produced by aortic coar
ctation for 5 days, resulted in ventricular hypertrophy (heart/body we
ight, 4.05 +/- 0.19 us. 3.42 +/- 0.16 mg/g; P < 0.02) and a 3.4-fold i
ncrease in beta MHC messenger RNA content. However, beta MHC promoter
activity in vivo was not significantly different between rats experien
cing aortic coarctation and sham-operated rats (1.49 +/- 0.41 vs. 0.96
+/- 0.27 luciferase/chloramphenicol acetyltransferase, respectively)
and was similar to that in euthyroid animals. These results show that
beta MHC promoter activity is T-3 responsive in cultured myocytes and
in vivo, but that the increase in beta MHC messenger RNA observed in t
he in vivo pressure-overloaded myocardium cannot be explained entirely
by transcription control mechanisms.